Methods of producing T cell populations enriched for stable regulatory T-cells
View Patent ↗The present invention provides methods for producing cell populations enriched for stable, regulatory T cells (Tregs). In particular, the invention relates to methods for culturing T cells such that the final culture is enriched for stable, regulatory T cells. It also relates to methods for stabilizing regulatory T cells. Also provided are compositions enriched for stable, regulatory T cells, which are useful for treating individuals in need of such treatment. The methods and compositions disclosed herein can also be used to treat an individual suffering from an immune-mediated disease.
1. A method for producing a population of cells having stable, regulatory T cells, the method comprising culturing an initial population of regulatory-T-cells in the presence of interleukin-2, an anti-CD3 antibody, an anti-CD28 antibody, and an isolated oligdeoxyonucleotide (ODN) having a phosphorothioate backbone, to expand the initial population of regulatory T-cells, wherein the ODN having a phosphothioate backbone is between 11 and 49 nucleotides in length, and wherein the initial population of regulatory T-cells has been enriched for CD4+CD25+CD127 lo or CD4+CD25+CD127− cells by obtaining a sample comprising CD4+CD25+CD127 lo or CD4+CD25+CD127− cells, identifying cells that are CD4+CD25+CD127 lo or CD4+CD25+CD127−, and collecting the identified cells to produce the initial population of regulatory T-cells enriched for CD4+CD25+CD127 lo or CD4+CD25+Cd127− cells.
2. The method of claim 1 , wherein the stable regulatory T-cells express CD4 and at least one marker selected from the group consisting of Foxp3 and Helios.
3. The method of claim 1 , wherein the isolated ODN is selected from the group consisting of an isolated ODN 21 nucleotides in length, an isolated ODN 22 nucleotides in length, an isolated ODN 23 nucleotides in length, an isolated ODN 24 nucleotides in length, and an isolated ODN 25 nucleotides in length.
4. The method of claim 1 , wherein the isolated ODN is approximately 25 nucleotides length.
5. The method of claim 1 , wherein the enriched population of T-cells is enriched for CD4+CD25+CD127 lo or CD4+CD25+CD127− cells relative to the level of CD4+CD25+CD127 lo or CD4+CD25+CD127− cells present in blood.
6. The method of claim 1 , wherein at least some of the initial regulatory T cells are Foxp3+.
7. The method of claim 6 , wherein at least some of the initial regulatory T cells are also Helios+.
8. The method of claim 1 , wherein at least some of the initial regulatory T cells are CD25 hi .
9. The method of claim 8 , wherein at least some of the initial regulatory T-cells are Helios positive.
10. The method of claim 1 , wherein expansion of the initial population of regulatory T-cells results in an expanded population of cells in which at least 60% of the cells are TSDR-demethylated, stable, regulatory T-cells.
11. A method for stabilizing T regulatory cells, the method comprising culturing an initial population of regulatory T-cells, in the presence of interleukin-2, an anti-CD3 antibody, an anti-CD28 antibody, and an isolated oligdeoxyonucleotide (ODN) having a phosphorothioate backbone, to expand the initial regulatory T-cell population, wherein the ODN having a phosphothioate backbone is between 11 and 49 nucleotides in length, and wherein the initial population of regulatory T-cells has been enriched for CD4+CD25+CD127 lo or CD4+CD25+CD127− cells by obtaining a sample comprising CD4+CD25+CD127 lo or CD4+CD25+CD127− cells, identifying cells that are CD4+CD25+CD127 lo or CD4+CD25+CD127−, and collecting the identified cells to produce the initial population of regulatory T-cells enriched for CD4+CD25+CD127 lo or CD4+CD25+Cd127− cells.
12. The method of claim 11 , wherein at least some of the initial regulatory T cells are Foxp3+.
13. The method of claim 11 , wherein at least some of the initial regulatory T-cells are CD25 hi .
14. The method of claim 11 , wherein at least some of the initial regulatory T-cells are Helios positive.
15. The method of claim 11 , wherein the enriched population of T-cells is enriched for CD4+CD25+CD127 lo or CD4+CD25+CD127− cells relative to the level of CD4+CD25+CD127 lo or CD4+CD25+CD127− cells present in blood.